| 1. |
Evans, M. E., Gregory, D. W., Schaffner, W., and McGee, Z. A. (1985) Tularemia: a 30-year experience with 88 cases. Medicine
64, 251–269.
|
| |
| 2. |
Fortier, A. H., Slayter, M. V., Ziemba, R., Meltzer, M. S., and Nacy, C. A. (1991) Live vaccine strain of Francisella tularensis: infection and immunity in mice. Infect. Immun.
59, 2922–2928.
|
| |
| 3. |
Larson, C. L., Wicht, W., and Jellison, W. L. (1955) A new organism resembling P. tularensis isolated from water. Public Health Rep.
70, 253–258.
|
| |
| 4. |
Hollis, D. G., Weaver, R. E., Steigerwalt, A. G., Wenger, J. D., Moss, C. W., and Brenner, D. J. (1989) Francisella philomiragia comb. nov. (formerly Yersinia philomiragia) and Francisella tularensis biogroup novicida (formerly Francisella novicida) associated with human disease. J. Clin. Microbiol.
27, 1601–1608.
|
| |
| 5. |
Wenger, J. D., Hollis, D. G., Weaver, R. E., Baker, C. N., Brown, G. R., Brenner, D. J., and Broome, C. V. (1989) Infection
caused by Francisella philomiragia (formerly Yersinia philomiragia). Ann. Intern. Med.
110, 888–892.
|
| |
| 6. |
White, J. D., Rooney, J. R., Prickett, P. A., Derrenbacher, E. B., Beard, C. W., and Griffith, W. R. (1964) Pathogenesis of
experimental respiratory tularemia in monkeys. J. Infect. Dis.
114, 277–283.
|
| |
| 7. |
Anthony, L. S. D., and Kongshavn, P. A. L. (1988) H-2 Restriction in acquired cell-mediated immunity to infection with Francisella tularensis LVS. Infect. Immun.
56, 452–456.
|
| |
| 8. |
Surcel, H.-M., Ilonen, J., Poikonen, K., and Herva, E. (1989) Francisella tularensis-specific T-cell clones are human leukocyte antigen class II restricted, secrete interleukin-2 and gamma interferon, and induce
immunoglobulin production. Infect. Immun.
57, 2906–2908.
|
| |
| 9. |
Anthony, L. S. D., Ghadirian, E., Nestel, F. P., and Kongshavn, P. A. L. (1989) The requirement for gamma interferon in resistance
of mice to experimental tularemia. Microb. Pathog.
7, 421–428.
|
| |
| 10. |
Leiby, D. A., Fortier, A. H., Crawford, R. M., Schreiber, R. D., and Nacy, C. A. (1992) In vivo modulation of the murine immune
response to Francisella tularensis LVS by administration of anticytokine antibodies. Infect. Immun.
60, 84–89.
|
| |
| 11. |
Anthony, L. S. D., Morrissey, P. J., and Nano, F. E. (1992) Growth inhibition of Francisella tularensis live vaccine strain by IFN-γ-activated macrophages is mediated by reactive nitrogen intermediates derived from L-arginine metabolism. J. Immunol.
148, 1829–1834.
|
| |
| 12. |
Anthony, L. S. D., Burke, R. D., and Nano, F. E. (1991) Growth of Francisella spp. in rodent macrophages. Infect. Immun.
59, 3291–3296.
|
| |
| 13. |
Anthony, L. S. D., Gu, M., Cowley, S. C., Leung, W. W. S., and Nano, F. E. (1991) Transformation and allelic replacement in
Francisella spp. J. Gen. Microbiol.
137, 2697–2703.
|
| |
| 14. |
Way, J. C., Davis, M. A., Morisato, D., Roberts, D. E., and Kleckner, N. (1984) New Tn10 derivatives for transposon mutagenesis and for constructing of lacZ operon fusions by transposition. Gene
32, 369–379.
|
| |
| 15. |
Chamberlain, R. E. (1965) Evaluation of live tularemia vaccine prepared in a chemically defined medium. Appl. Microbiol.
13, 232–235.
|
| |
| 16. |
Sandstrom, G., Lofgren, S., and Tarnvik, A. (1988) A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced
sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes. Infect. Immun.
56, 1194–1202.
|
| |
| 17. |
Halmann, M., Benedict, M., and Mager, J. (1967) Nutritional requirements of Pasteurella tularensis for growth from small inocula. J. Gen. Microbiol.
49, 451–460.
|
| |